Benadryl
Showing 1 - 25 of 222
Pain, Insomnia Trial in Guangzhou (Compound ibuprofen polyrelease tablets, reference 1 (R1): Ibuprofen Tablets (Motrin
Not yet recruiting
- Pain
- Insomnia
- Compound ibuprofen polyrelease tablets
- reference 1 (R1): Ibuprofen Tablets (Motrin IB®)reference 2 (R2): Diphenhydramine Hydrochloride Tablets (Benadryl®)
-
Guangzhou, Guangdong, ChinaZhujiang Hospital of Southern Medical University
Feb 6, 2023
Cocaine-Related Disorders Trial in Birmingham (Psilocybin, Diphenhydramine)
Recruiting
- Cocaine-Related Disorders
-
Birmingham, AlabamaUAB Outpatient Clinical Research Unit
Jan 6, 2023
Gastric Adenocarcinoma, Carcinomatosis Trial in Houston (Paclitaxel, Dexamethasone, Diphenhydramine)
Not yet recruiting
- Gastric Adenocarcinoma
- Carcinomatosis
- Paclitaxel
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Aug 7, 2023
Autism, Autism Spectrum Disorder Trial (Diphenhydramine, Placebo)
Not yet recruiting
- Autism
- Autism Spectrum Disorder
- Diphenhydramine
- Placebo
- (no location specified)
Aug 12, 2022
Follicular Lymphoma Trial (Axicabtagene Ciloleucel, Cyclophosphamide, Fludarabine phosphate)
Not yet recruiting
- Follicular Lymphoma
- Axicabtagene Ciloleucel
- +5 more
- (no location specified)
Sep 21, 2023
Diseases of Oesophagus Stomach and Duodenum Trial in Houston (Dexamethasone, Diphenhydramine, Famotidine)
Active, not recruiting
- Diseases of Oesophagus Stomach and Duodenum
- Dexamethasone
- +5 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Sep 7, 2022
Multisystem Inflammatory Syndrome in Children (MIS-C) Associated With Coronavirus Disease (COVID-19) Trial (Remestemcel-L,
Available
- Multisystem Inflammatory Syndrome in Children (MIS-C) Associated With Coronavirus Disease (COVID-19)
- Remestemcel-L
- +2 more
- (no location specified)
Apr 12, 2022
Crohn Disease Trial in Los Angeles (drug, procedure, biological)
Recruiting
- Crohn Disease
- Mesna
- +12 more
-
Los Angeles, CaliforniaCedars-Sinai Medical Center
Mar 23, 2022
Lung Cancer Trial in Houston (DOTAP:Chol-TUSC2, Erlotinib, Dexamethasone)
Terminated
- Lung Cancer
- DOTAP:Chol-TUSC2
- +3 more
-
Houston, TexasUT MD Anderson Cancer Center
Feb 11, 2022
Alcoholism Trial in Chicago (Ethanol, Placebo, Diphenhydramine)
Recruiting
- Alcoholism
- Ethanol
- +3 more
-
Chicago, IllinoisClinical Addictions Research Laboratory
Feb 4, 2022
Primary Total Hip Arthroplasty, Primary Total Knee Arthroplasty Trial in Columbia (drug, dietary supplement, behavioral)
Recruiting
- Primary Total Hip Arthroplasty
- Primary Total Knee Arthroplasty
- Diphenhydramine (Benadryl)
- +2 more
-
Columbia, MissouriUniversity of Missouri Health System
Oct 25, 2021
Cannabis Hyperemesis Syndrome Trial in United States (Droperidol Injectable Product, Diphenhydramine)
Recruiting
- Cannabis Hyperemesis Syndrome
- Droperidol Injectable Product
- Diphenhydramine
-
Austintown, Ohio
- +3 more
Feb 16, 2022
Hip Surgery, Post Operative Pain Control Trial (Lumbar Plexus Catheter, Lumbar Epidural Catheter, Patient Controlled Analgesia)
Terminated
- Hip Surgery
- Post Operative Pain Control
- Lumbar Plexus Catheter
- +10 more
- (no location specified)
Oct 4, 2021
Kidney Cancer Trial in Houston (Pazopanib, Temsirolimus, Quality of Life Assessment)
Completed
- Kidney Cancer
- Pazopanib
- +3 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Aug 24, 2021
Pompe Disease Trial in Gainesville (genetic, drug, other)
Completed
- Pompe Disease
- Recombinant Adeno-Associated Virus Acid Alpha-Glucosidase
- +7 more
-
Gainesville, FloridaClinical and Translational Research Building (CTRB), University
Mar 24, 2022
Oncology Patients Receiving Chemo Trial in United States (Cetirizine HCl 10 mg/mL, Diphenhydramine 50 mg/mL, anti-CD20 such as
Completed
- Oncology Patients Receiving Chemotherapy
- Cetirizine HCl 10 mg/mL
- +2 more
-
Napa, California
- +6 more
Apr 25, 2022
HPV-Related Squamous Cell Carcinoma, HNSCC Trial in Chicago (drug, procedure, radiation)
Active, not recruiting
- HPV-Related Squamous Cell Carcinoma
- HNSCC
- nab-paclitaxel
- +12 more
-
Chicago, IllinoisUniversity of Chicago Medical Center
Nov 12, 2021
Lymphoma, Non-Hodgkin, Advanced Stage Diffuse Large B-Cell Non-Hodgkin's Lymphoma Trial in Vancouver (Cyclophosphamide,
Active, not recruiting
- Lymphoma, Non-Hodgkin
- Advanced Stage Diffuse Large B-Cell Non-Hodgkin's Lymphoma
- Cyclophosphamide
- +14 more
-
Vancouver, British Columbia, CanadaBC Cancer Agency
Jul 20, 2021
Kidney Transplant, Adult Living Donor Kidney Transplant Recipients, Renal Transplant Trial in United States (biological, drug,
Recruiting
- Kidney Transplant
- +3 more
- Polyclonal Regulatory T Cells
- +10 more
-
Birmingham, Alabama
- +5 more
Feb 22, 2022
Migraine Headache Trial in Louisville (Auricular Acupuncture, Ketorolac 0.5mg/kg, max 30mg, Metoclopramide 0.1 mg/kg, max 10mg)
Recruiting
- Migraine Headache
- Auricular Acupuncture
- +4 more
-
Louisville, Kentucky
- +1 more
Jun 17, 2021
Kidney Transplant Trial in Canada, United States (Infliximab, Methylprednisolone, Mycophenolate Mofetil)
Completed
- Kidney Transplant
- Infliximab
- +9 more
-
Birmingham, Alabama
- +14 more
Jul 19, 2022
Acute Liver Failure, Fulminant Hepatic Failure, Hepatic Encephalopathy Trial in United States (High-dose methylprednisolone,
Recruiting
- Acute Liver Failure
- +4 more
- High-dose methylprednisolone
- +6 more
-
Los Angeles, California
- +19 more
Dec 5, 2022
Lupus Erythematosus, Systemic Trial run by the NCI (drug, biological, other, procedure)
Completed
- Lupus Erythematosus, Systemic
- fludarabine phosphate
- +9 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Dec 9, 2020